Ankang Lü

487 total citations
11 papers, 244 citations indexed

About

Ankang Lü is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ankang Lü has authored 11 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Epidemiology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ankang Lü's work include Adipokines, Inflammation, and Metabolic Diseases (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Pulmonary Hypertension Research and Treatments (2 papers). Ankang Lü is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Pulmonary Hypertension Research and Treatments (2 papers). Ankang Lü collaborates with scholars based in China, United States and Japan. Ankang Lü's co-authors include Ying Yu, Huan Liu, Qian Zhu, Caojian Zuo, Yuhu He, Daile Jia, Shengkai Zuo, Deping Kong, Richard Breyer and Yong Ji and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Pharmacology and Experimental Therapeutics and Cardiovascular Research.

In The Last Decade

Ankang Lü

11 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ankang Lü China 9 82 54 47 47 35 11 244
Rachele Pandolfi Spain 9 138 1.7× 75 1.4× 98 2.1× 84 1.8× 30 0.9× 13 348
Huahui Yu China 10 95 1.2× 63 1.2× 42 0.9× 46 1.0× 15 0.4× 32 248
Tracy Clarke United States 6 119 1.5× 94 1.7× 51 1.1× 43 0.9× 31 0.9× 7 426
Joon-Young Kim South Korea 8 179 2.2× 31 0.6× 34 0.7× 53 1.1× 38 1.1× 13 383
Thorben Ravekes Germany 6 63 0.8× 56 1.0× 27 0.6× 57 1.2× 24 0.7× 6 216
Hongwei Yang China 10 186 2.3× 34 0.6× 47 1.0× 44 0.9× 28 0.8× 24 404
L Adhikary Nepal 6 180 2.2× 29 0.5× 49 1.0× 44 0.9× 22 0.6× 14 340
Xiangjun Zeng China 7 130 1.6× 31 0.6× 54 1.1× 55 1.2× 45 1.3× 18 348

Countries citing papers authored by Ankang Lü

Since Specialization
Citations

This map shows the geographic impact of Ankang Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankang Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankang Lü more than expected).

Fields of papers citing papers by Ankang Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankang Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankang Lü. The network helps show where Ankang Lü may publish in the future.

Co-authorship network of co-authors of Ankang Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Ankang Lü. A scholar is included among the top collaborators of Ankang Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankang Lü. Ankang Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Meili, Die Pu, Yuxing Zhao, et al.. (2020). Sulforaphane protects against skeletal muscle dysfunction in spontaneous type 2 diabetic db/db mice. Life Sciences. 255. 117823–117823. 29 indexed citations
2.
Zhu, Shiyu, Ankang Lü, Yuxing Zhao, et al.. (2020). [Expressions of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases 1 in skeletal muscles of aged rats with sarcopenia].. PubMed. 40(1). 104–109. 1 indexed citations
3.
Kong, Deping, Juanjuan Li, Yujun Shen, et al.. (2017). Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1. Journal of Pharmacology and Experimental Therapeutics. 360(3). 435–444. 18 indexed citations
4.
Jia, Daile, Yuhu He, Qian Zhu, et al.. (2017). RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension. Cardiovascular Research. 113(6). 586–597. 45 indexed citations
5.
Jia, Daile, Qian Zhu, Huan Liu, et al.. (2017). Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression. Circulation Cardiovascular Genetics. 10(1). 28 indexed citations
6.
Kong, Deping, Yujun Shen, Guizhu Liu, et al.. (2016). PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation. The Journal of Experimental Medicine. 213(10). 2209–2226. 58 indexed citations
7.
Sun, Jiateng, et al.. (2013). Glycation of high-density lipoprotein in type 2 diabetes mellitus. Chinese Medical Journal. 126(21). 4162–4165. 8 indexed citations
8.
Zhao, Liangping, et al.. (2010). Influence of insulin resistance on long-term outcomes in patients with coronary artery disease after sirolimus-eluting stent implantation. Chinese Medical Journal. 123(6). 651–657. 3 indexed citations
9.
Ning, Guang, et al.. (2009). The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population. Diabetes Research and Clinical Practice. 85(2). 213–219. 15 indexed citations
10.
11.
Lu, Lin, Qi Zhang, Ruiyan Zhang, et al.. (2007). Elevation of tumor necrosis factor-α, interleukin-1β and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes. Chinese Medical Journal. 120(6). 479–484. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachele Pandolfi Breakdown of academic impact, for papers by Huahui Yu Breakdown of academic impact, for papers by Tracy Clarke Breakdown of academic impact, for papers by Joon-Young Kim Breakdown of academic impact, for papers by Thorben Ravekes Breakdown of academic impact, for papers by Hongwei Yang Breakdown of academic impact, for papers by L Adhikary Breakdown of academic impact, for papers by Xiangjun Zeng
Rankless by CCL
2026